Venture Capital for Biomedical Research

The strategic role of the private foundations Purnell Choppin observes in this issue (p. 16-17) that “the health of the biomedical research enterprise [in the United States] is inseparable from the health of the NIH.” Since two thirds of federal support for biomedical research in this country goes into or through the NIH, and since that amounts to one third of total national support for basic research in biomedicine, one can only agree with the statement of the president of the How

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The strategic role of the private foundations Purnell Choppin observes in this issue (p. 16-17) that “the health of the biomedical research enterprise [in the United States] is inseparable from the health of the NIH.” Since two thirds of federal support for biomedical research in this country goes into or through the NIH, and since that amounts to one third of total national support for basic research in biomedicine, one can only agree with the statement of the president of the Howard Hughes Medical Institute.

Nonetheless, the Hughes organization, which will disburse about $230 million in 1988, is certainly making a mark on the course and character of U.S. biomedical research. With assets of $5 billion and an annual budget comparable to that of a midsized institute at the NIH, HHMI has focused professional and public attention on non-governmental funding sources.

Besides government and industry support for biomedical research, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo